Virtue Diagnostics racks up $100M to make in vitro testing affordable, accessible in China

Retrieved on: 2022-01-06 21:11:45

Tags for this article:

Click the tags to see associated articles and topics

Virtue Diagnostics racks up $100M to make in vitro testing affordable, accessible in China. View article details on hiswai:

Excerpt

venture capital (VC) in vitro diagnostics Lilly Ventures Perkinelmer Sequoia Capital China series B. Your browser does not support JavaScript!

Article found on: www.fiercebiotech.com